Unit

UNIT 7.38 Measuring Mast Cell Mediator Release

  1. Hye Sun Kuehn,
  2. Madeleine Radinger,
  3. Alasdair M. Gilfillan

Published Online: 1 NOV 2010

DOI: 10.1002/0471142735.im0738s91

Current Protocols in Immunology

Current Protocols in Immunology

How to Cite

Kuehn, H. S., Radinger, M. and Gilfillan, A. M. 2010. Measuring Mast Cell Mediator Release. Current Protocols in Immunology. 91:IV:7.38:7.38.1–7.38.9.

Author Information

  1. Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

Publication History

  1. Published Online: 1 NOV 2010
  2. Published Print: NOV 2010

Abstract

Mediators released from activated mast cells are responsible for the allergic inflammatory reactions associated with disease states such as anaphylaxis and atopy. These mediators are released as a consequence of immediate degranulation and phospholipid metabolism upon mast cell activation, followed by delayed cytokine gene expression. Thus, techniques that monitor indices of these events in mast cell culture systems, in association with biochemical analysis of parameters of cell signaling, are critical to our understanding of the molecular mechanisms regulating mast cell–mediated disease. Furthermore, these systems can be adapted for high-throughput screens to identify potential inhibitors of mast cell activation that may provide potential leads for novel therapies for these diseases. In this unit, we describe approaches that can be readily used or adapted to a variety of rodent and human mast cell culture systems for the determination of degranulation, phospholipid-derived inflammatory mediator production, and cytokine generation. Curr. Protoc. Immunol. 91:7.38.1-7.38.9. © 2010 by John Wiley & Sons, Inc.

Keywords:

  • cytokines;
  • degranulation;
  • eicosanoids;
  • FcɛRI;
  • human mast cells (HuMCs);
  • KIT;
  • mouse bone marrow–derived mast cells (BMMCs);
  • stem cell factor (SCF)